UTHR Financial Facts
(Loss) income from discontinued operations, net of tax: 0Discontinued operations (in dollars per share): 0.07
See Full Income Statement
Deferred tax assets: 191M
Other current assets: 6.28M
See Full Balance Sheet
United Therapeutics Corp. (UTHR) Earnings
|
Expand Research on UTHR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +24.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/3/22 | Q222 | N/A | $4.42 | N/A | N/A | $458.97M | N/A | N/A | N/A | ||
| 5/4/22 | Q122 | $5.03 | $3.34 | +$1.69 | $461.9M | $420.02M | N/A | ![]() | ![]() | Details | |
| 2/24/22 | Q421 | $3.51 | $3.72 | -$0.21 | $415.2M | $427.62M | N/A | ![]() | ![]() | Details | |
| 11/3/21 | Q321 | $4.16 | $3.59 | +$0.57 | $444.7M | $421.45M | N/A | ![]() | ![]() | Details | |
| 8/4/21 | Q221 | $4.09 | $3.02 | +$1.07 | $446.5M | $378.75M | N/A | ![]() | ![]() | Details | |
| 5/5/21 | Q121 | $3.49 | $2.94 | +$0.55 | $379.1M | $368.95M | N/A | ![]() | ![]() | Details | |
| 2/24/21 | Q420 | $3.31 | $3.14 | +$0.17 | $384.9M | $362.04M | N/A | ![]() | ![]() | Details | |
| 10/28/20 | Q320 | $3.88 | $2.78 | +$1.10 | $380.1M | $356.95M | N/A | ![]() | ![]() | Details |

